New stroke drug shows promise in helping patients recover faster

NCT ID NCT07396337

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called QHRD106 in people who have had a recent ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help patients recover better and have less disability. About 320 adults aged 18 to 80 who have not received standard clot-busting treatment will receive either the drug or a placebo within 24 hours of their stroke. The main measure of success is how many patients can function independently 90 days later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nanjing Drum Tower Hospital

    RECRUITING

    Nanjing, Jiangsu, 210008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••